Table 1 Association of UCHL3 RNF6 levels with clinical and pathological features of cervical cancer patients
Characteristics | N | Â | RNF6 expression | P-value | |
|---|---|---|---|---|---|
| Â | Low | High | |||
Age, years | Â | Â | Â | Â | Â |
≤ 45 | 53 |  | 31 (20.8%) | 22 (14.8%) | 0.887 |
> 45 | 96 |  | 55 (36.9%) | 41 (27.5%) | |
Histological type | Â | Â | Â | Â | Â |
Squamous cell carcinoma | 127 | Â | 72 (48.3%) | 55 (36.9%) | 0.863 |
Adenocarcinoma | 17 | Â | 11 (7.4%) | 6 (4.0%) | |
Adenosquamous carcinoma | 5 | Â | 3(2.0%) | 2(1.3%) | |
Tumor size, cm | Â | Â | Â | Â | Â |
≤ 3 | 51 |  | 37 (24.8%) | 14 (9.4%) | 0.008 |
> 3 | 98 |  | 49 (32.9%) | 49 (32.9%) | |
FIGO stage | Â | Â | Â | Â | Â |
I-II | 114 | Â | 73(49.0%) | 41 (27.5%) | 0.005 |
III-IV | 35 | Â | 13 (8.7%) | 22 (14.8%) | |
Lymph node metastasis | Â | Â | Â | Â | Â |
No | 63 | Â | 37 (24.8%) | 26 (17.5%) | 0.831 |
Yes | 86 | Â | 49 (32.9%) | 37 (24.8%) | |